AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32172521 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study 35045859 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition-sensitive homestead food production (HFP) program
Number of subjects: 44
Study 35045859 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 44
Study 32803791 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-operative methadone
Number of subjects: 137
Study 32803791 — intervention group
Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 137
Study 32886727 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional lactation support (frequency, duration, and form)
Number of subjects: 159
Study 34617303 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural activation (BA) + Antidepressant (AD)
Number of subjects: 76
Study 34617303 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial-based cognitive therapy (TBCT) + Antidepressant (AD)
Number of subjects: 76
Study 34617303 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 76
Study 33725856 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care + acupuncture
Number of subjects: 50
Study 33725856 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 50
Study 34245614 — intervention group
Group type: EXPERIMENTAL
Intervention: 25G Franseen needle
Number of subjects: 88
Study 34245614 — intervention group
Group type: COMPARATOR
Intervention: 22G Franseen needle
Number of subjects: 88
Study 615729350 — intervention group
Group type: EXPERIMENTAL
Intervention: EBUS-FNA
Number of subjects: 100
Study 615729350 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-FNA
Number of subjects: 100
Study 615729350 — intervention group
Group type: COMPARATOR
Intervention: Standard endoscopic methods (EBB, TBLB, TBNA)
Number of subjects: 100
Study 34967942 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Brain Stimulation (DBS)
Number of subjects: 0
Study 34967942 — intervention group
Group type: EXPERIMENTAL
Intervention: Vagus Nerve Stimulation (VNS)
Number of subjects: 0
Study 34967942 — intervention group
Group type: COMPARATOR
Intervention: Care as Usual (CAU)
Number of subjects: 0
Study 33181672 — intervention group
Group type: EXPERIMENTAL
Intervention: Intelligent rehabilitation assistant system
Number of subjects: 50
Study 33181672 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation (control group)
Number of subjects: 50
Study 35703373 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of clobetasol 0.05% lotion and oral NAC
Number of subjects: 30
Study 35703373 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of clobetasol 0.05% lotion and oral PTX
Number of subjects: 30
Study 35703373 — intervention group
Group type: COMPARATOR
Intervention: Clobetasol 0.05% lotion
Number of subjects: 30
Study 34503977 — intervention group
Group type: EXPERIMENTAL
Intervention: Ripretinib 150 mg once daily
Number of subjects: 129
Study 34503977 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study 35943885 — intervention group
Group type: EXPERIMENTAL
Intervention: Holmium Laser Enucleation of the Prostate (HoLEP)
Number of subjects: 181
Study 35943885 — intervention group
Group type: COMPARATOR
Intervention: Bipolar Plasmakinetic Enucleation of the Prostate (BPEP)
Number of subjects: 181
Study 35943885 — intervention group
Group type: EXPERIMENTAL
Intervention: Both HoLEP and BPEP
Number of subjects: 181
Study 33120891 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body cryotherapy (WBC) - 3-min exposure to −120 C, twice a day for 7 days
Number of subjects: 20
Study 33120891 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 33120891 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body cryotherapy (WBC)
Number of subjects: 20
Study 36270928 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender oil inhalation therapy for 5 min (L group)
Number of subjects: 45
Study 36270928 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment of foot soak and lavender oil inhalation therapy (FL group)
Number of subjects: 45
Study 36270928 — intervention group
Group type: COMPARATOR
Intervention: Foot soak treatment for 20 min (F group)
Number of subjects: 45
Study 33571004 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal volunteering (at least 60 minutes per week for 6 months)
Number of subjects: 445
Study 33571004 — intervention group
Group type: COMPARATOR
Intervention: Control (no volunteering)
Number of subjects: 445
Study 33992747 — intervention group
Group type: EXPERIMENTAL
Intervention: Message highlighting the risk of disease transmission from factory farms
Number of subjects: 0
Study 33992747 — intervention group
Group type: EXPERIMENTAL
Intervention: Message highlighting the threat to worker's health created by factory farms
Number of subjects: 0
Study 33992747 — intervention group
Group type: COMPARATOR
Intervention: Traditional messages highlighting environmental, personal health, or animal welfare implications of factory farmed meat consumption
Number of subjects: 0
Study 33992747 — intervention group
Group type: EXPERIMENTAL
Intervention: Messages highlighting personal health benefits of reduced meat consumption
Number of subjects: 0
Study 32527941 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy and targeted therapy
Number of subjects: 451
Study 32527941 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean CTC count
Number of subjects: 451
Study 32527941 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-modifications (increased and reduced)
Number of subjects: 451
Study 36160398 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.5 μg kg−1) and butorphanol (20 μg kg−1)
Number of subjects: 56
Study 36160398 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (0.05 mg kg−1) and butorphanol (20 μg kg−1)
Number of subjects: 56
Study 32085907 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-modal intervention (cognitive training, mindfulness meditation, and aerobic exercise) over 16 weeks
Number of subjects: 424
Study 32085907 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-modal intervention
Number of subjects: 424
Study 35717239 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT) using PREVENA PLUS™ Incision Management System
Number of subjects: 154
Study 35717239 — intervention group
Group type: COMPARATOR
Intervention: Conventional wound dressing
Number of subjects: 154
Study 33409971 — intervention group
Group type: EXPERIMENTAL
Intervention: RT combined with whey protein supplementation (RTP+PRO)
Number of subjects: 63
Study 33409971 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 63
Study 33409971 — intervention group
Group type: EXPERIMENTAL
Intervention: RT combined with placebo (RTP)
Number of subjects: 63
Study 33409971 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein supplementation (PRO)
Number of subjects: 63
Study 35906659 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured and individualized exercise intervention (9-month multimodal exercise program, 6 months supervised twice a week, followed by 3 months with one supervised and one unsupervised session)
Number of subjects: 350
Study 35906659 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured and individualized exercise intervention
Number of subjects: 350
Study 35906659 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard medical care, general written physical activity advice, and an activity tracker without structured exercise program)
Number of subjects: 350
Study 35906659 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 350
Study 33509840 — intervention group
Group type: EXPERIMENTAL
Intervention: Unite for a Better Life (UBL) intervention delivered to men
Number of subjects: 4379
Study 33509840 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 4379
Study 32780747 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass-media campaign (televised for ten days)
Number of subjects: 702
Study 32780747 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (control group who did not see the campaign)
Number of subjects: 702
Study 35580976 — intervention group
Group type: EXPERIMENTAL
Intervention: Anifrolumab (300 mg every 4 weeks for 48 weeks)
Number of subjects: 825
Study 35580976 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 825
Study 35178149 — intervention group
Group type: EXPERIMENTAL
Intervention: Training using the adapted Pathfinder International Teaching Package on the use of misoprostol in the management of PPH
Number of subjects: 68
Study 35178149 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 68
Study 32931497 — intervention group
Group type: EXPERIMENTAL
Intervention: Development group
Number of subjects: 6172
Study 32931497 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation group
Number of subjects: 6172
Study 35175171 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Promotion Program for Children with Asthma (HPPCA)
Number of subjects: 74
Study 35175171 — intervention group
Group type: COMPARATOR
Intervention: Control group (no further education)
Number of subjects: 74
Study 34475811 — intervention group
Group type: EXPERIMENTAL
Intervention: Video encouraging digital social activity
Number of subjects: 988
Study 34475811 — intervention group
Group type: EXPERIMENTAL
Intervention: Video sensitizing to COVID‐19 related stigma
Number of subjects: 988
Study 34475811 — intervention group
Group type: COMPARATOR
Intervention: Informational sheet only
Number of subjects: 988
Study 35247871 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab (10 mg/kg intravenously; once every 2 weeks for up to 12 months)
Number of subjects: 713
Study 35247871 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 713
Study 32977820 — intervention group
Group type: EXPERIMENTAL
Intervention: Matrix Model treatment combined with MPH
Number of subjects: 100
Study 32977820 — intervention group
Group type: COMPARATOR
Intervention: Matrix Model treatment
Number of subjects: 100
Study 32977820 — intervention group
Group type: COMPARATOR
Intervention: MPH 10mg/day in the first month, 7.5mg/day in the second month and 5mg/day in the third month
Number of subjects: 100
Study 32977820 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 35587607 — intervention group
Group type: EXPERIMENTAL
Intervention: Conexiones program (telephone-delivered cancer parenting education)
Number of subjects: 18
Study 34329624 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus doxycycline (200 mg on day 1, then 100 mg once daily for the following 6 days)
Number of subjects: 2508
Study 34329624 — intervention group
Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 2508
Study 34329624 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus doxycycline
Number of subjects: 2508
Study 36105246 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic surgery for OA
Number of subjects: 236
Study 33913215 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of sleep disorders
Number of subjects: 351932
Study 33913215 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-organic sleep disorders, hypersomnia, and sleep apnea
Number of subjects: 351932
Study 33913215 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep disorders
Number of subjects: 351932
Study 32590780 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-step cervical vertebra rehabilitation exercises
Number of subjects: 90
Study 32590780 — intervention group
Group type: COMPARATOR
Intervention: Basic nursing measures
Number of subjects: 90
Study 35441345 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic treatment initiated in 87 patients (73% of relapsed patients)
Number of subjects: 246
Study 35441345 — intervention group
Group type: EXPERIMENTAL
Intervention: Local therapy (irradiation or surgical intervention) in 27 patients (23% of relapsed patients)
Number of subjects: 246
Study 35441345 — intervention group
Group type: COMPARATOR
Intervention: Early relapse (< 6 months)
Number of subjects: 246
Study 35441345 — intervention group
Group type: COMPARATOR
Intervention: Microsatellite-unstable (MSI) tumor status
Number of subjects: 246
Study 32781050 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training with medical air
Number of subjects: 29
Study 32781050 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training with supplemental oxygen
Number of subjects: 29
Study 33108201 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-GroEL antibody
Number of subjects: 100
Study 33108201 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-CagA antibody
Number of subjects: 100
Study 33108201 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-HP1118/Ggt, Anti-HP0516/HsIU, Anti-HP0243/NapA, Anti-HP1293/RpoA, Anti-HP0371/FabE, Anti-HP0875/KatA antibodies
Number of subjects: 100
Study 33108201 — intervention group
Group type: EXPERIMENTAL
Intervention: Model with anti-Ggt, anti-HslU, anti-NapA, and anti-CagA
Number of subjects: 100
Study 32100498 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) treatment at specific acupuncture points (Fengshi, Futu, Zusanli, Shangjuxu, Fenglong, Xuanzhong, Diji, Sanyinjiao) for 20-30 min, twice a day for 7 days.
Number of subjects: 140
Study 32100498 — intervention group
Group type: COMPARATOR
Intervention: Routine rehabilitation treatment (control group).
Number of subjects: 140
Study 35226095 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational plus family weight loss program (M + FWL)
Number of subjects: 241
Study 35226095 — intervention group
Group type: COMPARATOR
Intervention: Comprehensive health education control program
Number of subjects: 241
Study 35226095 — intervention group
Group type: EXPERIMENTAL
Intervention: Online tailored program
Number of subjects: 241
Study 35226095 — intervention group
Group type: COMPARATOR
Intervention: Online control program
Number of subjects: 241
Study 34831600 — intervention group
Group type: EXPERIMENTAL
Intervention: Modular coordinating case management
Number of subjects: 852
Study 34831600 — intervention group
Group type: COMPARATOR
Intervention: Supported self-management
Number of subjects: 852
Study 32178648 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer-based walking intervention (6-month program with 3 months of pedometers and weekly step count targets)
Number of subjects: 60
Study 32178648 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer-based walking intervention
Number of subjects: 60
Study 32178648 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 60
Study 32822222 — intervention group
Group type: EXPERIMENTAL
Intervention: Microwave ablation, radiotherapy, and chemotherapy
Number of subjects: 100
Study 32822222 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy with pemetrexed disodium or gemcitabine hydrochloride, cisplatin chemotherapy, and conventional radiotherapy
Number of subjects: 100
Study 32507902 — intervention group
Group type: EXPERIMENTAL
Intervention: N-wave measurement
Number of subjects: 59
Study 32507902 — intervention group
Group type: EXPERIMENTAL
Intervention: PhNR measurement
Number of subjects: 59
Study 35543941 — intervention group
Group type: EXPERIMENTAL
Intervention: Head acupuncture combined with exercise therapy
Number of subjects: 64
Study 35543941 — intervention group
Group type: COMPARATOR
Intervention: Conventional acupuncture
Number of subjects: 64
Study 33594766 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression garment (21–22 mmHg) worn during and for 6 h after exercise
Number of subjects: 16
Study 33594766 — intervention group
Group type: COMPARATOR
Intervention: Non-compressed leg
Number of subjects: 16
Study 33594766 — intervention group
Group type: EXPERIMENTAL
Intervention: Compressed leg
Number of subjects: 16
Study 33594766 — intervention group
Group type: EXPERIMENTAL
Intervention: Both legs (compressed and non-compressed)
Number of subjects: 16
Study 32160125 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen matrix dressing (Tebaderm)
Number of subjects: 61
Study 32160125 — intervention group
Group type: COMPARATOR
Intervention: Saline-moistened gauze dressing (control)
Number of subjects: 61
Study 34228612 — intervention group
Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (an anabolic steroid) in combination with vitamin D
Number of subjects: 64
Study 34228612 — intervention group
Group type: COMPARATOR
Intervention: Control group (no anabolic steroid treatment)
Number of subjects: 64
Study 32100946 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline-directed LVAD destination therapy (GD-LVAD-DT) using the HeartMate 3 (HM3) continuous flow pump
Number of subjects: 80
Study 32100946 — intervention group
Group type: COMPARATOR
Intervention: Guideline-directed medical therapy (GDMT)
Number of subjects: 80
Study 34389340 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery (esophagectomy with 2‐ or 3‐field lymph node dissection)
Number of subjects: 368
Study 34389340 — intervention group
Group type: COMPARATOR
Intervention: Chemoradiotherapy (2 courses of 5‐fluorouracil 700 mg/m2 on days 1‐4 and cisplatin 70 mg/m2 on day 1 every 4 weeks with concurrent radiation 60 Gy)
Number of subjects: 368
Study 34389340 — intervention group
Group type: COMPARATOR
Intervention: Chemoradiotherapy
Number of subjects: 368
Study 34389340 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 368
Study 35730768 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic cluster set protocol
Number of subjects: 10
Study 35730768 — intervention group
Group type: COMPARATOR
Intervention: Traditional set protocol
Number of subjects: 10
Study 35730768 — intervention group
Group type: COMPARATOR
Intervention: Undulating cluster protocols
Number of subjects: 10
Study 35730768 — intervention group
Group type: EXPERIMENTAL
Intervention: All protocols
Number of subjects: 10
Study 33909587 — intervention group
Group type: EXPERIMENTAL
Intervention: PsyCovidApp (n=248)
Number of subjects: 482
Study 33909587 — intervention group
Group type: COMPARATOR
Intervention: Control app (n=234)
Number of subjects: 482
Study 32475278 — intervention group
Group type: EXPERIMENTAL
Intervention: Microorganism-directed oral antibiotics for three months
Number of subjects: 142
Study 32475278 — intervention group
Group type: COMPARATOR
Intervention: No antibiotics
Number of subjects: 142
Study 33661990 — intervention group
Group type: EXPERIMENTAL
Intervention: iFlash3000 CLIA analyzer for measuring IgM and IgG titers against SARS-CoV-2
Number of subjects: 199
Study 32565469 — intervention group
Group type: EXPERIMENTAL
Intervention: Early cryoprecipitate transfusion
Number of subjects: 0
Study 32565469 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 0
Study 35273807 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Mindfulness Intervention (BMI)
Number of subjects: 55
Study 35273807 — intervention group
Group type: COMPARATOR
Intervention: Health Enhancement Program (HEP)
Number of subjects: 55
Study 35273807 — intervention group
Group type: COMPARATOR
Intervention: Both BMI and HEP
Number of subjects: 55
Study 32301166 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual acupuncture at acupoints LI 10 and LI 11 on the affected side
Number of subjects: 96
Study 32301166 — intervention group
Group type: COMPARATOR
Intervention: Sham laser acupuncture at acupoints LI 10 and LI 11
Number of subjects: 96
Study 32301166 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual acupuncture
Number of subjects: 96
Study 32577927 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive learner handover (LH)
Number of subjects: 42
Study 32577927 — intervention group
Group type: COMPARATOR
Intervention: Negative learner handover (LH)
Number of subjects: 42
Study 32577927 — intervention group
Group type: COMPARATOR
Intervention: No learner handover (LH)
Number of subjects: 42
Study 32056873 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortioxetine 10 mg once daily during the open-label period
Number of subjects: 1106
Study 32056873 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortioxetine 5 mg, 10 mg, or 20 mg
Number of subjects: 1106
Study 32056873 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1106
Study 35166327 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time, personalized chat messaging on relapse prevention via WhatsApp for 3 months
Number of subjects: 108
Study 35166327 — intervention group
Group type: COMPARATOR
Intervention: Generic text messaging on the harms of smoking and benefits of quitting for 3 months
Number of subjects: 108
Study 33184726 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-month dual antiplatelet therapy (DAPT) followed by clopidogrel monotherapy
Number of subjects: 750
Study 33184726 — intervention group
Group type: COMPARATOR
Intervention: 12-month dual antiplatelet therapy (DAPT)
Number of subjects: 750
Study 32050207 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior penetrating incisions
Number of subjects: 50
Study 32050207 — intervention group
Group type: COMPARATOR
Intervention: Intrastromal arcuate incisions
Number of subjects: 50
Study 37587599 — intervention group
Group type: EXPERIMENTAL
Intervention: Amulet
Number of subjects: 1878
Study 37587599 — intervention group
Group type: COMPARATOR
Intervention: Watchman
Number of subjects: 1878
Study 33559576 — intervention group
Group type: EXPERIMENTAL
Intervention: Unicortical locked plate and screw fixation
Number of subjects: 16
Study 33559576 — intervention group
Group type: COMPARATOR
Intervention: Bicortical non-locked plate and screw fixation
Number of subjects: 16
Study 33657185 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led mental health intervention
Number of subjects: 20
Study 32504862 — intervention group
Group type: EXPERIMENTAL
Intervention: Mizoribine (MZR)
Number of subjects: 80
Study 32504862 — intervention group
Group type: COMPARATOR
Intervention: Mycophenolate Mofetil (MMF)
Number of subjects: 80
Study 32504862 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade II-IV acute GVHD
Number of subjects: 80
Study 36010995 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapentadol (TP) 50 to 500 mg/day
Number of subjects: 114
Study 36010995 — intervention group
Group type: COMPARATOR
Intervention: Tapentadol plus Duloxetine (DLX) 60 to 120 mg/day
Number of subjects: 114
Study 36010995 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapentadol (TP)
Number of subjects: 114
Study 36010995 — intervention group
Group type: COMPARATOR
Intervention: Tapentadol plus Duloxetine (DLX)
Number of subjects: 114
Study 32732104 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity cycle-based exercise
Number of subjects: 99